Annual CFO:
-$347.69M+$10.30M(+2.88%)Summary
- As of today, DNLI annual cash from operations is -$347.69 million, with the most recent change of +$10.30 million (+2.88%) on December 31, 2024.
- During the last 3 years, DNLI annual cash from operations has fallen by -$136.31 million (-64.48%).
- DNLI annual cash from operations is now -183.55% below its all-time high of $416.15 million, reached on December 31, 2020.
Performance
DNLI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$75.30M+$56.17M(+42.73%)Summary
- As of today, DNLI quarterly cash from operations is -$75.30 million, with the most recent change of +$56.17 million (+42.73%) on June 30, 2025.
- Over the past year, DNLI quarterly cash from operations has increased by +$15.92 million (+17.45%).
- DNLI quarterly cash from operations is now -114.65% below its all-time high of $513.91 million, reached on December 31, 2020.
Performance
DNLI Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$349.62M+$15.92M(+4.36%)Summary
- As of today, DNLI TTM cash from operations is -$349.62 million, with the most recent change of +$15.92 million (+4.36%) on June 30, 2025.
- Over the past year, DNLI TTM cash from operations has increased by +$41.24 million (+10.55%).
- DNLI TTM cash from operations is now -183.16% below its all-time high of $420.40 million, reached on March 31, 2021.
Performance
DNLI TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
DNLI Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +2.9% | +17.4% | +10.6% |
| 3Y3 Years | -64.5% | -75.5% | -57.5% |
| 5Y5 Years | -129.4% | -73.7% | -140.4% |
DNLI Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -64.5% | +2.9% | -32.0% | +42.7% | -51.1% | +15.3% |
| 5Y | 5-Year | -183.6% | +2.9% | -114.7% | +42.7% | -183.2% | +15.3% |
| All-Time | All-Time | -183.6% | +2.9% | -114.7% | +42.7% | -183.2% | +15.3% |
DNLI Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$75.30M(+42.7%) | -$349.62M(+4.4%) |
| Mar 2025 | - | -$131.47M(-57.0%) | -$365.54M(-5.1%) |
| Dec 2024 | -$347.69M(+2.9%) | -$83.72M(-41.6%) | -$347.69M(+4.1%) |
| Sep 2024 | - | -$59.14M(+35.2%) | -$362.64M(+7.2%) |
| Jun 2024 | - | -$91.22M(+19.7%) | -$390.86M(+5.3%) |
| Mar 2024 | - | -$113.62M(-15.2%) | -$412.81M(-15.3%) |
| Dec 2023 | -$357.99M(-46.3%) | -$98.66M(-12.9%) | -$357.99M(-7.8%) |
| Sep 2023 | - | -$87.36M(+22.8%) | -$332.00M(-10.0%) |
| Jun 2023 | - | -$113.17M(-92.5%) | -$301.68M(-30.4%) |
| Mar 2023 | - | -$58.80M(+19.1%) | -$231.41M(+5.4%) |
| Dec 2022 | -$244.72M(-15.8%) | -$72.66M(-27.4%) | -$244.72M(-3.0%) |
| Sep 2022 | - | -$57.05M(-33.0%) | -$237.55M(-7.0%) |
| Jun 2022 | - | -$42.90M(+40.5%) | -$221.94M(+4.9%) |
| Mar 2022 | - | -$72.11M(-10.1%) | -$233.26M(-10.3%) |
| Dec 2021 | -$211.39M | -$65.49M(-58.1%) | -$211.39M(-157.4%) |
| Sep 2021 | - | -$41.43M(+23.6%) | $368.02M(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$54.22M(-7.9%) | $409.54M(-2.6%) |
| Mar 2021 | - | -$50.24M(-109.8%) | $420.40M(+1.0%) |
| Dec 2020 | $416.15M(+374.6%) | $513.91M(>+9900.0%) | $416.15M(+386.2%) |
| Sep 2020 | - | $86.00K(+100.2%) | -$145.41M(+17.3%) |
| Jun 2020 | - | -$43.36M(+20.4%) | -$175.93M(-0.1%) |
| Mar 2020 | - | -$54.49M(-14.4%) | -$175.75M(-15.9%) |
| Dec 2019 | -$151.58M(-402.5%) | -$47.64M(-56.5%) | -$151.58M(-1310.3%) |
| Sep 2019 | - | -$30.43M(+29.5%) | -$10.75M(+29.0%) |
| Jun 2019 | - | -$43.17M(-42.4%) | -$15.13M(-9.8%) |
| Mar 2019 | - | -$30.32M(-132.5%) | -$13.78M(-127.5%) |
| Dec 2018 | $50.12M(+165.4%) | $93.19M(+367.6%) | $50.12M(+181.6%) |
| Sep 2018 | - | -$34.82M(+16.7%) | -$61.41M(-131.0%) |
| Jun 2018 | - | -$41.82M(-224.6%) | -$26.58M(-274.4%) |
| Mar 2018 | - | $33.58M(+283.1%) | $15.24M(+183.1%) |
| Dec 2017 | -$76.64M(-6.6%) | -$18.34M(+0.2%) | -$18.34M(+0.2%) |
| Dec 2016 | -$71.91M(-377.7%) | -$18.37M | -$18.37M |
| Dec 2015 | -$15.05M | - | - |
FAQ
- What is Denali Therapeutics Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. annual cash from operations year-on-year change?
- What is Denali Therapeutics Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. quarterly cash from operations year-on-year change?
- What is Denali Therapeutics Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. TTM cash from operations year-on-year change?
What is Denali Therapeutics Inc. annual cash from operations?
The current annual cash from operations of DNLI is -$347.69M
What is the all-time high annual cash from operations for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high annual cash from operations is $416.15M
What is Denali Therapeutics Inc. annual cash from operations year-on-year change?
Over the past year, DNLI annual cash from operations has changed by +$10.30M (+2.88%)
What is Denali Therapeutics Inc. quarterly cash from operations?
The current quarterly cash from operations of DNLI is -$75.30M
What is the all-time high quarterly cash from operations for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high quarterly cash from operations is $513.91M
What is Denali Therapeutics Inc. quarterly cash from operations year-on-year change?
Over the past year, DNLI quarterly cash from operations has changed by +$15.92M (+17.45%)
What is Denali Therapeutics Inc. TTM cash from operations?
The current TTM cash from operations of DNLI is -$349.62M
What is the all-time high TTM cash from operations for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high TTM cash from operations is $420.40M
What is Denali Therapeutics Inc. TTM cash from operations year-on-year change?
Over the past year, DNLI TTM cash from operations has changed by +$41.24M (+10.55%)